Compare Amgen, Inc. (AMGN) vs Kroger Co (KR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amgen, Inc. vs Kroger Co — how do they compare? Amgen, Inc. trades at $363.66 (market cap $196.12B), while Kroger Co trades at $60.45 (market cap $37.09B). The key difference: Amgen, Inc. is far larger — about 5.3× Kroger Co's market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| AMGN | KR | |
|---|---|---|
Market Cap | $196.12B | $37.09B |
Sector | Health | Consumer Staples |
52-Week High | $388.16 | $75.60 |
52-Week Low | $271.18 | $55.53 |
Enterprise Value | $241.41B | $57.18B |
Dividend Yield | 2.77% | 2.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Kroger (KR) trades at $60.54, up 1.14% today, near the analyst consensus price target of $68.63. The stock shows bullish technical signals despite a mixed earnings history, with recent beats in Q3 and Q4 2025 but a miss in Q1 2026. Fundamentals reveal a low P/S ratio of 0.26 and steady dividends, while the recent $1.65 billion acquisition of Giant Eagle aims to expand Midwest presence amid intense grocery competition.
KR offers value with solid cash flow and growth initiatives, but risks include margin pressure from industry competition and integration challenges from acquisitions. Analyst sentiment is positive with 48% buy ratings, supporting a cautious bullish outlook for patient investors focused on long-term retail consolidation benefits.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Kroger Co
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →
